Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate
- PMID: 27002850
- DOI: 10.3109/21691401.2016.1160917
Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate
Abstract
Eye is a vital organ of our body and any complication not only poses the risk of serious medical condition but also economic burden on the individual. Timolol maleate is one of the preferable therapeutic agents for the management of glaucoma. Globally, eye drops are among the most common and popular conventional formulations, but they are also associated with some limitations in terms of therapeutic response, bioavailability, dosing frequency and poor patient compliance. Present paper gives an overview of the drug delivery systems developed for management of glaucoma, advances and novel approaches with special emphasis on timolol drug delivery.
Keywords: Eye; glaucoma; ocular; ocular drug delivery; ophthalmic; timolol; topical.
Similar articles
-
Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo.Drug Deliv. 2011 Sep-Oct;18(7):502-10. doi: 10.3109/10717544.2011.595839. Epub 2011 Jul 26. Drug Deliv. 2011. PMID: 21790329
-
The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.Eur J Pharm Sci. 2017 Jul 15;105:188-194. doi: 10.1016/j.ejps.2017.05.020. Epub 2017 May 12. Eur J Pharm Sci. 2017. PMID: 28506871
-
A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.Exp Eye Res. 2015 Mar;132:115-23. doi: 10.1016/j.exer.2015.01.022. Epub 2015 Jan 26. Exp Eye Res. 2015. PMID: 25633346
-
Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertension.Expert Opin Pharmacother. 2008 Jan;9(1):137-43. doi: 10.1517/14656566.9.1.137. Expert Opin Pharmacother. 2008. PMID: 18076345 Review.
-
Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.Expert Opin Pharmacother. 2009 Aug;10(12):2015-24. doi: 10.1517/14656560903124388. Expert Opin Pharmacother. 2009. PMID: 19618994 Review.
Cited by
-
A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension.Asian J Pharm Sci. 2022 Nov;17(6):938-948. doi: 10.1016/j.ajps.2022.11.001. Epub 2022 Nov 17. Asian J Pharm Sci. 2022. PMID: 36600899 Free PMC article.
-
The Effect of Polymers on Drug Release Kinetics in Nanoemulsion In Situ Gel Formulation.Polymers (Basel). 2022 Jan 21;14(3):427. doi: 10.3390/polym14030427. Polymers (Basel). 2022. PMID: 35160417 Free PMC article.
-
Topical Medication Therapy for Glaucoma and Ocular Hypertension.Front Pharmacol. 2021 Dec 1;12:749858. doi: 10.3389/fphar.2021.749858. eCollection 2021. Front Pharmacol. 2021. PMID: 34925012 Free PMC article. Review.
-
A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma.Int J Mol Sci. 2020 Dec 4;21(23):9267. doi: 10.3390/ijms21239267. Int J Mol Sci. 2020. PMID: 33291737 Free PMC article.
-
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma.Curr Med Chem. 2024;31(13):1608-1619. doi: 10.2174/0109298673255220231010073215. Curr Med Chem. 2024. PMID: 37855339 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical